IP Verse

Methods For Determining Fraction Of Fetal Nucleic Acids In Maternal Samples - EP3006573B1

PatentPatent Analysis

EP3006573

VERINATA HEALTH
Application Number
EP15181244A
Filing Date
Dec 1, 2010
Status
Opposition Rejected
Jun 25, 2021
Grant Date
Mar 7, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3492601B1
EP3567124B1
EP3456844B1

Bibliography

The patent EP3006573B1 was granted to Verinata Health on Mar 7, 2018 following the initial filing on Dec 1, 2010 under the application number EP15181244A . The current legal status of the patent is Opposition Rejected.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

LEEMINGDec 7, 2018ADMISSIBLE
QIAGENDec 4, 2018ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents